Roggwil, May 6, 2021 – Since May 2020, the development of a successor model to the current tinniwell has been underway. The new device will be significantly smaller and will come in a more modern design. The production of the circuit board has already begun: https://www.youtube.com/watch?v=idwDwwCREp0

Despite the currently tense situation regarding the availability of electronic components on the global market, the supplier has secured all components. Therefore, there will be no shortages in availability.

++ About Resaphene Suisse AG

Resaphene Suisse AG, based in Roggwil, Switzerland, is a medical technology company that was founded in 2015 and has been selling a tinnitus therapy device under the name tinniwell since 2016.

++ Contact for inquiries:

Resaphene Suisse AG
Ms. Anke Rauterkus (Chief Executive Officer)
Bahnhofplatz 5
9322 Egnach
Switzerland
T. +41 714500668
a.rauterkus@resaphene.ch